From: The altered immunological status of children conceived by assisted reproductive technology
 | Gn dose | Gn days | Estradiol | Progesterone | ||||
---|---|---|---|---|---|---|---|---|
Viaribles | R | P | R | P | R | P | R | P |
% T cells (CD3+)a | −0.12 | 0.53 | −0.02 | 0.94 | − 0.17 | 0.41 | − 0.28 | 0.14 |
% B cells (CD19+)a | 0.11 | 0.56 | −0.23 | 0.25 | −0.06 | 0.76 | 0.03 | 0.89 |
% NK cells (CD16 + CD56+)a | 0.11 | 0.57 | 0.23 | 0.25 | 0.26 | 0.20 | 0.17 | 0.37 |
% CD8 + T cells a | 0.27 | 0.15 | −0.09 | 0.67 | −0.03 | 0.87 | −0.07 | 0.71 |
% CD4+ T cells a | −0.27 | 0.15 | 0.17 | 0.38 | 0.10 | 0.62 | −0.32 | 0.09 |
% TH1 (CD3 + CD8-IFN-γ+) b | −0.01 | 0.95 | −0.06 | 0.79 | −0.02 | 0.92 | −0.12 | 0.55 |
% TH17 (CD3 + CD8-IL-17+) b | −0.15 | 0.45 | 0.05 | 0.81 | 0.10 | 0.63 | −0.30 | 0.13 |
% Treg (CD4 + CD25hi + Foxp3+)a | −0.06 | 0.75 | 0.04 | 0.83 | 0.01 | 0.97 | 0.10 | 0.63 |
IFH-γ (pg/mL) a | 0.32 | 0.14 | −0.29 | 0.19 | − 0.33 | 0.13 | − 0.01 | 0.98 |
IL-4 (pg/mL) a | −0.06 | 0.80 | 0.49 | 0.02 | 0.50 | 0.02 | −0.13 | 0.56 |
IFN-γ / IL-4 a | 0.16 | 0.49 | −0.46 | 0.03 | −0.54 | 0.01 | 0.04 | 0.86 |
IL-17A (pg/mL) a | 0.34 | 0.13 | 0.14 | 0.56 | 0.09 | 0.69 | −0.20 | 0.38 |
IL-10 (pg/mL) a | 0.07 | 0.75 | 0.02 | 0.94 | 0.01 | 0.96 | −0.01 | 0.99 |